| Patent Number |
Title Of Patent |
Date Issued |
| RE35359 |
Amine salts of azo pigments based on pyrazolone derivatives |
October 22, 1996 |
| Compounds of formula ##STR1## wherein a and b are each independently of the other halogen, --CH.sub.3, --C.sub.2 H.sub.5, --OC.sub.2 H.sub.5 or the group of formula --NHCO--C.sub.1 -C.sub.4 alkyl, c and d are each independently of the other hydrogen, halogen, --CH.sub.3, --C.sub. |
| RE35009 |
Diketopyrrolopyrrole pigments in platelet form |
August 1, 1995 |
| Organic pigments selected from the diketopyrrolopyrrole, azo, isoindolinone and isoindoline series, which pigments consist of .Iadd.at least .Iaddend.50% by weight of platelets which are from 5 to 50 .mu.m long, 2 to 50 .mu.m wide and 0.01 to 5 .mu.m thick, with the proviso that the |
| RE34990 |
Oral therapeutic system having systemic action |
July 4, 1995 |
| The invention relates to a therapeutic system for peroral administration and having systemic action, which system is in the form of a coated and/or laminated mono-compartment system for administering carbamazepine. The therapeutic system comprises(a) a wall made of a material which is pe |
| RE34514 |
Electrically conductive composition of polyheteroaromatic compounds and polymeric sulfates |
January 18, 1994 |
| A composition comprising (a) at least one oxidized polycationic polyheteroaromatic compound and (b) at least one polyanion of a film-forming thermoplastic polymer containing sulfated alcohol groups ##STR1## in repeating structural units. The composition has high electrical conduc |
| RE33489 |
Photolytically cleavable, N-acylated sterically hindered amines |
December 11, 1990 |
| Sterically hindered cyclic amines which are substituted by a photoactivatable acyl group at the basic nitrogen atom can be deacylated by irradiation with UV light. This is advantageous if the basicity of the amines proves troublesome during application. Examples of such photoactivata |
| RE31343 |
Piperidine derivatives |
August 9, 1983 |
| New 1- and 4-substituted piperidines are stabilizers for organic material. They are produced by reacting corresponding 1-substituted piperidinols with acid chlorides or corresponding 4-substituted piperidines with a compound introducing into the 1-position a residue. |
| RE31342 |
Piperidyl carboxylates |
August 9, 1983 |
| New 1- and 4-substituted piperidines are stabilizers for organic material. They are produced by reacting corresponding 1-substituted piperidinols with acid chlorides or corresponding 4-substituted piperidines with a compound introducing into the 1-positon a residue. |
| RE31002 |
N-(3-Hydroxyaryl-propyl)-imides |
July 27, 1982 |
| The new N-[3-(3-hydroxyaryl)-2-hydroxypropyl]-imides may be prepared by reacting 3-(3-hydroxyaryl)-propenoxides with cyclic imides. These hydroxy compounds as well as their esters with carboxylic acids are highly effective in the stabilization of polymers, preferably of polyolefins, |
| RE30227 |
Agent for brightening and removing greyness from textiles |
March 11, 1980 |
| Agent for the preparation of the baths for brightening the color of and removing the greyness from white and pastel colored textiles which are made from synthetic fibers or which are provided with an easy-care finish and are made from cotton or blends thereof with synthetic fibers, which |
| RE29585 |
Heavy metal complexes of azo dyestuffs containing a 2-amino-3-hydroxypyridine as coupling compon |
March 21, 1978 |
| The heavy metal complexes of azo dyestuffs of formula ##STR1## where B is hydrogen, chloro or bromo and D is the residue of a diazo component of the benzene or naphthalene series that contains an hydroxyl, carboxyl or amino group in the position ortho to the azo group, are useful |
| RE29119 |
7-Pyridinium methyl carboxyl derivatives of 7-amino-cephalosporanic acid |
January 18, 1977 |
| 7-Aminopyridiniumacetylamino-cephalosporanic acids and derivatives thereof. The new compounds have antibacterial properties. |
| RE29112 |
Methods of forming a fiber reinforced pipe on an inflatable mandrel |
January 11, 1977 |
| A method and apparatus is provided for continuously making fiber reinforced plastic pipe in which a conveyor tube is formed on an axially fixed hollow rotatable mandrel. A plurality of bands of resin impregnated fiber elements are wound on the conveyor tube as it advances to provide the |
| D379714 |
Contact lens care container |
June 10, 1997 |
|
| D371678 |
Combined lid and package for contact lenses |
July 16, 1996 |
|
| D364956 |
Carrying case for gel bags |
December 12, 1995 |
|
| D361509 |
Dual-chamber bottle |
August 22, 1995 |
|
| D358466 |
Dispenser for ophthalmic solution |
May 16, 1995 |
|
| D352516 |
Tray |
November 15, 1994 |
|
| D352107 |
Inhaler |
November 1, 1994 |
|
| D319018 |
Cap for a contact lens vial or the like |
August 13, 1991 |
|
| D317359 |
Catalyst support for use in a contact lens disinfection unit |
June 4, 1991 |
|
| D314442 |
Tablet |
February 5, 1991 |
|
| D296018 |
Pharmaceutical tablet |
May 31, 1988 |
|
| D296006 |
Multicompartmentalized transdermal patch for administering drugs to the skin |
May 31, 1988 |
|
| 6134924 |
Apparatus for carrying out a process for the continuous dyeing of yarns with reactive dyes |
October 24, 2000 |
| The present invention relates to a process for the continuous dyeing of cellulose fibre yarns with reactive dyes and to an apparatus for carrying out this process.The process essentially comprises steps of impregnating yarn which has been continuously unwound at high speed from one or se |
| 6020153 |
Chimeric antibodies |
February 1, 2000 |
| The invention relates to murine/human chimeric monoclonal antibodies with high specificity to and affinity for human carcinoembryonic antigen (CEA), derivatives thereof, processes for the preparation of these antibodies and their derivatives, DNAs coding for heavy and light chains of the |
| 5955487 |
N-acyl-N-heterocyclylalkyamino acids compositions and method of use |
September 21, 1999 |
| The invention relates to N-acyl-N-heterocyclylalkylamino acids of the formula ##STR1## R.sub.1 is C.sub.1 -C.sub.7 alkyl that is unsubstituted or substituted by halogen or by hydroxy, or is C.sub.2 -C.sub.7 -alkenyl, C.sub.3 -C.sub.7 cycloalkyl, C.sub.3 -C.sub.7 cycloalkoxy, C.su |
| 5925367 |
Pest control with UV blockers and pheromones |
July 20, 1999 |
| A composition for controlling harmful insects and representatives of the order Acarina, containing as biologically active components a) a substance that modifies the behavior of the pests and b) at least one pesticidally active compound, wherein the biologically active components are con |
| 5922569 |
Process for the production of polypeptides |
July 13, 1999 |
| The invention concerns a method for the production of a polypeptide with the aid of genetically engineered yeast cells which contain not more than one functional CUP1 gene in the genome and carry a plasmid comprising a gene coding for said polypeptide and a functional CUP1 gene; and said |
| 5882698 |
Lens mold for use in a contact lens inspection apparatus |
March 16, 1999 |
| Collimated white light is transmitted through a transparent lens mold having a molded lens resting on a curved surface thereof. A telecentric lens and a camera having a digital output are used to view the illuminated lens to obtain pixel image data of the lens. The pixel image data is |
| 5843899 |
Use of insulin-like growth factors I and II for inhibition of inflammatory response |
December 1, 1998 |
| The present invention relates to methods for using IGF as inhibitors of inflammatory response, ischemic injury, and organ rejection. |
| 5843708 |
Chimeric antibodies |
December 1, 1998 |
| The invention relates to murine/human chimeric monoclonal antibodies with high specificity to and affinity for human carcinoembryonic antigen (CEA), derivatives thereof, processes for the preparation of these antibodies and their derivatives, DNAs coding for heavy and light chains of the |
| 5843676 |
Purified immunoglobulin-related factor, novel monoclonal antibodies, hybridoma cell lines, proce |
December 1, 1998 |
| The invention relates to novel purified human immunoglobulin E binding factors (IgE-BFs), its individual optionally glycosylated proteins, and fragments thereof, processes for the purification of IgE-BFs, novel monoclonal antibodies to lymphocyte cellular receptors for IgE (Fc.sub..e |
| 5837499 |
DNA encoding C5A receptor antagonists having substantially no agonist activity and methods of ex |
November 17, 1998 |
| Disclosed are polypeptide analogues of human C5a which are C5a receptor antagonists that exhibit substantially no analphylatoxin or agonist activity, and derivatives of the analogues, and dimeric forms of the analogues or derivatives. DNA molecules encoding the polypeptides and metho |
| 5837290 |
Process for the preparation of microcapsules |
November 17, 1998 |
| The invention relates to a process for the preparation of an aqueous suspension of microcapsules having a capsule wall of polyurea and encapsulating a water-immiscible pesticide, by dispersing a solution of a polyisocyanate in the sparingly water-soluble pesticide in water and subseq |
| 5827984 |
Apparatus for simulating the effect of the living organism on the change in shape, the disintegr |
October 27, 1998 |
| An apparatus for simulating the effect of a living organism on the change in shape, the disintegration and dissolution behaviour and the active-ingredient release of a pharmaceutical dosage form, including a beaker-shaped container for accommodating a test medium and the pharmaceutic |
| 5817887 |
Color-photographic recording material |
October 6, 1998 |
| A color-photographic recording material is described which contains a magenta coupler and, as stabilizer, at least one compound of the formula ##STR1## where the radicals are as defined in the specification. |
| 5807824 |
C5A receptor antagonists having substantially no agonist activity |
September 15, 1998 |
| Disclosed are polypeptide analogues of human C5a which are C5a receptor antagonists that exhibit substantially no analphylatoxin or agonist activity, and derivatives of the analogues, and dimeric forms of the analogues or derivatives. DNA molecules encoding the polypeptides and metho |
| 5739187 |
Semiconductor encapsulating epoxy resin compositions and semiconductor devices encapsulated ther |
April 14, 1998 |
| An epoxy resin composition comprising (A) 20-80 parts by weight of an epoxy resin, (B) 20-80 parts by weight of a curing agent, (C) 0.1-50 parts by weight of a phosphorus-containing flame retardant, and (D) 200-1,200 parts by weight of an inorganic filler cures into products having impro |
| 5736597 |
Stabilized organic material |
April 7, 1998 |
| o-Hydroxyphenyl-s-triazines of the formula I ##STR1## in which n is 1 to 4 and R.sub.1 to R.sub.7 are as defined in claim 1, can be used, in combination with sterically hindered amines of the polyalkylpiperidine type, for stabilizing organic polymers. Some of these compounds are |
| 5731266 |
Herbicidal compositions comprising diamino-1,3,5-triazine and chloroacetanilide herbicides and a |
March 24, 1998 |
| Flowable herbicidal compositions which contain an active component combination of at least one triazine and at least one chloroacetanilide with a surfactant component. This surfactant component, which consists of an anionic compound based on a monosulfuric acid ester of alkyl or alky |
| 5728676 |
Use of insulin-like growth factors I and II for inhibition of inflammatory response |
March 17, 1998 |
| The present invention relates to methods for using IGF as inhibitors of inflammatory response, ischemic injury, and organ rejection. |
| 5712249 |
Use of insulin-like growth factors I and II for inhibition of inflammatory response |
January 27, 1998 |
| The present invention relates to methods for using IGF as inhibitors of inflammatory response, ischemic injury, and organ rejection. |
| 5708148 |
Process for the production and refolding of unfused IGF-II protein in E. coli |
January 13, 1998 |
| A process for the preparation of a recombinant IGF-II (rIGF-II) without a covalently attached foreign protein moiety and without N-terminal attached methionine or a derivative of methionine or of a salt of said IGF-II, rIGF-II produced by said method, hybrid vectors comprising DNA encodi |
| 5708140 |
Production of proteins using 7B2 protein |
January 13, 1998 |
| The invention lies in the field of genetic engineering and, in particular, is concerned with the use of 7B2 as chaperone in vivo or in vitro. The invention accordingly concerns a method for producing a desired protein in vivo with the aid of recombinant cells capable of expressing 7B2 an |
| 5707690 |
Protective coating for wood |
January 13, 1998 |
| The invention relates to a method of protecting surfaces of wood against damage by light by treatment with a coating composition comprising a benzophenone of the formula I ##STR1## in which the substituents are defined as in claim 1. |
| 5702724 |
Process for the preparation of an oral solid dosage form containing diclofenac |
December 30, 1997 |
| The invention relates to a novel advantageous process for the preparation of an oral solid dosage form containing diclofenac or a pharmaceutically acceptable salt thereof. The dosage form is obtainable by direct compression of an inclusion compound consisting of diclofenac, or a salt |
| 5700482 |
Process for the preparation of a liposome dispersion under elevated pressure contents |
December 23, 1997 |
| The invention relates to a novel, advantageous process for the preparation of liposomes for the inclusion of water-soluble or hydrophilic substances or mixtures of substances, which process provides the surprising advantage, in comparison with known processes, that the proportion of |
| 5695782 |
Double-layered oxcarbazepine tablets |
December 9, 1997 |
| The invention relates to color-stable tablets for the therapeutic drug oxcarbazepine, which tablets are provided with a hydrophilic, permeable layer containing white pigments and a hydrophilic, permeable outer layer containing white pigments in combination with iron(II) oxide pigments. |
| 5693807 |
Substituted hydroquinone derivatives |
December 2, 1997 |
| The invention relates to substituted hydroquinone derivatives of the general formula I ##STR1## wherein R.sub.4 is lower alkyl and either R.sub.1 is hydroxy, halogen, a group of the formula --P(=O)(R.sub.5)R.sub.6 (Ia), a group of the formula --P.sup.+ (R.sub.7)(R.sub.8)R.sub.9 X |
